ViroCell Biologics ("ViroCell" or the "Company"), a cell and gene therapy ("CGT") contract development and manufacturing organization ("CDMO") specializing in GMP viral vector manufacturing for ...
Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...
LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
1d
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.
A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
The first-of-its-kind facility in India has received an investment of $75 million from the company to build it vertically ...
OXB honoured at 2025 CDMO Leadership Awards in 'Cell & Gene Therapy – Global' category Oxford, UK – 21 March 2025: OXB (LSE: ...
Bharat Biotech has launched India's first vertically integrated cell and gene therapy facility in Telangana, investing USD 75 ...
Hyderabad: Bharat Biotech International Limited (BBIL), has announced the launch of India's only vertically integrated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback